🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. Dexamethasone and N-acetylcysteine (NAC)

    Hospital Authority, Hong Kong

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  2. Dexamethasone and N-acetylcysteine (NAC)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  3. Dual chamber pacemeker

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  4. Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  5. Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms

    Sanofi-aventis Healthcare Pty Ltd

    Respiratory tract diseases

    approved small molecule active

    1 trial

  6. EFFIMIA 0,250 mg/0,035mg, Compresse

    Italfarmaco S.p.A.

    Female contraception.

    approved small molecule active

    1 trial

  7. EPIAO®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anaemia

    approved small molecule terminated

    1 trial

  8. Elobixibat 10mg

    International Peace Maternity and Child Health Hospital

    Chronic Constipation

    approved small molecule terminated

    1 trial

  9. Enema transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota, Placebo coloscopic transplant of Fecal microbiota, Double encapsulated oral transplant of fecal microbiota

    Pari Pharma GmbH

    Crohn’s disease

    approved small molecule active

    1 trial

  10. Entecavir + Placebo

    ShuGuang Hospital

    Liver Cirrhosis Due to Hepatitis B Virus

    approved small molecule active

    1 trial

  11. Enteric-Coated Mycophenolate Sodium (EC-MPS)

    Novartis Pharmaceuticals

    Renal Transplant

    approved small molecule completed

    1 trial

  12. Epidiolex 100 mg/mL Oral Solution

    Jazz Pharmaceuticals Ireland Limited

    Dravet Syndrome (DS)

    approved small molecule active

    1 trial

  13. Epinephrine (0.125 mg/inhalation)

    Amphastar France Pharmaceuticals

    Pharmacokinetics

    approved other completed

    1 trial

  14. Fill out Questionnaire

    Rhythm Pharmaceuticals Netherlands B.V.

    Bradycardia

    approved other completed

    1 trial

  15. Fluad Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted), Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Vaxigrip injektioneste, suspensio, esitäytetty ruisku. Kolmivalenttinen influenssarokote (virusfragmentit, inaktivoitu)., Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuva

    The George Institute

    Avian influenza and seasonal influenza

    approved small molecule active

    1 trial

  16. Fluocinolone Acetonide Intravitreal Implant 0.18 mg

    ANI PHARMACEUTICALS INC

    Uveitis, Posterior

    approved small molecule active

    1 trial

  17. Fluvirin(TIVf)

    Novartis Pharmaceuticals

    Influenza

    approved mab completed

    1 trial

  18. Fostair 200 microgram/6 microgram per actuation pressurised inhalation solution, Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution

    Chiesi Farmaceutici S.p.A

    Asthma

    approved small molecule active

    1 trial

  19. Freezor® Cardiac Cryoablation Catheter CryoConsole System

    Rhythm Pharmaceuticals Netherlands B.V.

    Tachycardia, Atrioventricular Nodal Reentry

    approved other completed

    1 trial

  20. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial

  21. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Lennox-Gastaut Syndrome

    approved small molecule terminated

    1 trial

  22. Glatiramer Acetate

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    approved small molecule terminated

    5 trials

  23. Guselkumab 1 mL PFS Placebo, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    approved small molecule active

    1 trial

  24. HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE

    The George Institute

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources